FDA Inspection 1181084 — HansBiomed USA, Inc.
The FDA completed an inspection of HansBiomed USA, Inc. on September 27, 2022 in Englewood Cliffs, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Englewood Cliffs, NJ (United States)